PortfoliosLab logo
PortfoliosLab logo
​
Tools
Performance Analysis
Portfolio Analysis
Risk Analysis
Optimization
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Screeners
Discussions
Big Pharma Split Corp. (PRM.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Big Pharma Split Corp. (PRM.TO)

Equity · Currency in CAD · Last updated Sep 19, 2024

Company Info

ISINCA08934P1080
CUSIP08934P108
SectorFinancial Services
IndustryAsset Management

Highlights

Market CapCA$16.52M
EPS (TTM)CA$1.01
PE Ratio14.47
Total Revenue (TTM)CA$2.46M
Gross Profit (TTM)CA$2.15M
EBITDA (TTM)CA$1.46M
Year RangeCA$12.23 - CA$14.80
Target PriceCA$2.00
Short Ratio1.19

Share Price Chart

Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Popular comparisons: PRM.TO vs. LIFE.TO

Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in Big Pharma Split Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

-5.00%0.00%5.00%10.00%AprilMayJuneJulyAugustSeptember
9.01%
7.77%
PRM.TO (Big Pharma Split Corp.)
Benchmark (^GSPC)

Returns By Period

Big Pharma Split Corp. had a return of 13.17% year-to-date (YTD) and 9.68% in the last 12 months.

PeriodReturnBenchmark
Year-To-Date13.17%17.79%
1 month-0.32%0.18%
6 months10.35%7.53%
1 year9.68%26.42%
5 years (annualized)14.85%13.48%
10 years (annualized)N/A10.85%

Monthly Returns

The table below presents the monthly returns of PRM.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.

JanFebMarAprMayJunJulAugSepOctNovDecTotal
20246.87%0.27%-2.40%-1.90%3.85%0.73%6.43%-0.65%13.17%
20230.85%-3.42%2.89%5.04%-2.51%2.24%-0.05%3.67%-4.20%-5.80%2.88%1.87%2.83%
20220.24%-2.07%9.26%-1.94%3.01%-3.21%0.36%-8.50%-1.58%8.25%8.37%-2.57%8.32%
20217.34%0.68%0.61%2.23%4.37%0.93%2.95%3.45%-10.45%4.39%0.74%6.97%25.61%
2020-3.27%-14.81%-5.34%20.04%-0.08%6.92%0.74%5.41%-8.56%-11.75%20.87%1.35%5.01%
20191.03%3.02%5.81%-7.49%-2.44%3.74%-3.35%3.05%4.84%8.55%3.78%3.30%25.30%
20180.72%-5.15%-5.38%-3.14%4.11%1.50%4.44%4.60%5.62%-10.22%8.75%-7.56%-3.65%
2017-0.00%-1.71%-1.71%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PRM.TO is 63, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of PRM.TO is 6363
PRM.TO (Big Pharma Split Corp.)
The Sharpe Ratio Rank of PRM.TO is 6262Sharpe Ratio Rank
The Sortino Ratio Rank of PRM.TO is 5353Sortino Ratio Rank
The Omega Ratio Rank of PRM.TO is 5656Omega Ratio Rank
The Calmar Ratio Rank of PRM.TO is 7575Calmar Ratio Rank
The Martin Ratio Rank of PRM.TO is 6767Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Big Pharma Split Corp. (PRM.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.

PRM.TO
Sharpe ratio
The chart of Sharpe ratio for PRM.TO, currently valued at 0.49, compared to the broader market-4.00-2.000.002.000.49
Sortino ratio
The chart of Sortino ratio for PRM.TO, currently valued at 0.81, compared to the broader market-6.00-4.00-2.000.002.004.000.81
Omega ratio
The chart of Omega ratio for PRM.TO, currently valued at 1.12, compared to the broader market0.501.001.502.001.12
Calmar ratio
The chart of Calmar ratio for PRM.TO, currently valued at 0.77, compared to the broader market0.001.002.003.004.005.000.77
Martin ratio
The chart of Martin ratio for PRM.TO, currently valued at 2.48, compared to the broader market-10.00-5.000.005.0010.0015.0020.002.48
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.06, compared to the broader market-4.00-2.000.002.002.06
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-6.00-4.00-2.000.002.004.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.37, compared to the broader market0.501.001.502.001.37
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.85, compared to the broader market0.001.002.003.004.005.001.85
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 11.09, compared to the broader market-10.00-5.000.005.0010.0015.0020.0011.09

Sharpe Ratio

The current Big Pharma Split Corp. Sharpe ratio is 0.49. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Big Pharma Split Corp. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio0.001.002.003.00AprilMayJuneJulyAugustSeptember
0.49
2.41
PRM.TO (Big Pharma Split Corp.)
Benchmark (^GSPC)

Dividends

Dividend History

Big Pharma Split Corp. granted a 8.97% dividend yield in the last twelve months. The annual payout for that period amounted to CA$1.31 per share.

PeriodTTM2023202220212020201920182017
DividendCA$1.31CA$1.24CA$1.24CA$1.95CA$1.24CA$1.24CA$1.24CA$0.10

Dividend yield

8.97%9.00%8.49%13.31%9.23%8.81%9.99%0.73%

Monthly Dividends

The table displays the monthly dividend distributions for Big Pharma Split Corp.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024CA$0.10CA$0.18CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.00CA$0.90
2023CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.24
2022CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.24
2021CA$0.10CA$0.82CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.95
2020CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.24
2019CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.24
2018CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$0.10CA$1.24
2017CA$0.10CA$0.10

Dividend Yield & Payout

Dividend Yield
5.0%10.0%15.0%9.0%
Big Pharma Split Corp. has a dividend yield of 8.97%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%78.3%
Big Pharma Split Corp. has a payout ratio of 78.30%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

-8.00%-6.00%-4.00%-2.00%0.00%AprilMayJuneJulyAugustSeptember
-1.03%
-1.36%
PRM.TO (Big Pharma Split Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Big Pharma Split Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Big Pharma Split Corp. was 41.69%, occurring on Mar 23, 2020. Recovery took 83 trading sessions.

The current Big Pharma Split Corp. drawdown is 1.03%.

Depth

Start

To Bottom

Bottom

To Recover

End

Total

-41.69%Jan 21, 202044Mar 23, 202083Jul 21, 2020127
-21.68%Apr 11, 2022117Sep 27, 202244Nov 29, 2022161
-19.86%Aug 18, 202051Oct 29, 202029Dec 9, 202080
-19.65%Oct 10, 201854Dec 24, 2018212Oct 30, 2019266
-18.93%Jan 31, 201860Apr 26, 201897Sep 14, 2018157

Volatility

Volatility Chart

The current Big Pharma Split Corp. volatility is 3.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.

2.00%3.00%4.00%5.00%6.00%7.00%AprilMayJuneJulyAugustSeptember
3.84%
3.33%
PRM.TO (Big Pharma Split Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Big Pharma Split Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Annual
Quarterly
0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Big Pharma Split Corp..

Loading data...

Income Statement

Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
TTM
Revenue

Total Revenue

—

Cost Of Revenue

—

Gross Profit

—
Operating Expenses

Selling, General & Admin Expenses

—

R&D Expenses

—

Depreciation And Amortization

—

Total Operating Expenses

—
Income

Income Before Tax

—

Operating Income

—

EBITDA

—

EBIT

—

Earnings From Continuing Operations

—

Net Income

—

Income Tax Expense

—

Other Non-Operating Income (Expenses)

—

Extraordinary Items

—

Discontinued Operations

—

Effect Of Accounting Charges

—

Non Recurring

—

Minority Interest

—

Other Items

—

Interest Income

—

Interest Expense

—

Net Interest Income

—
Values in undefined except per share items